US BROKER MOVES: CBOE upgraded at Morgan Stanley; DD downgraded at JPM

UPGRADES WeBull (BULL) Upgraded from Sector Perform to Sector Outperform at Scotiabank Cboe Global Markets (CBOE) Upgraded from Underweight to Overweight at Morgan Stanley; PT USD 358 Elastic (ESTC) Upgraded from Neutral to Buy at Monness, Crespi, Hardt; PT USD 120 Fastly (FSLY) Upgraded from Perform to Outperform at Oppenheimer; PT USD 35 ICON (ICLR) Upgraded from Underperform to Neutral at BofA Securities; PT USD 185 Jack Henry & Associates (JKHY) Upgraded from Neutral to Overweight at Piper Sandler; PT USD 175 South Bow (SOBO) Upgraded from Underweight to Equalweight at Barclays; PT USD 33 VF Corp (VFC) Upgraded from Underweight to Neutral at JPMorgan; PT USD 18 DOWNGRADES Alignment Healthcare (ALHC) Downgraded from Outperform to Market Perform at William Blair Astera Labs (ALAB) Downgraded from Outperform to Market Perform at Northland DuPont (DD) Downgraded from Overweight to Neutral at JPMorgan; PT USD 145 Gemini Space Station (GEMI) Downgraded from Equalweight to Underweight at Morgan Stanley; PT USD 4.75 Illinois Tool Works (ITW) Downgraded from Overweight to Neutral at JPMorgan; PT USD 277 Knife River (KNF) Downgraded from Outperform to Sector Perform at RBC Capital; PT USD 58 Pacira BioSciences (PCRX) Downgraded from Buy to Neutral at H.C. Wainwright; PT USD 36.50 Pluralsight (PS) Downgraded from Neutral to Sell at Citi; PT USD 45 Smithfield Foods (SFD) Downgraded from Buy to Neutral at BofA Securities; PT USD 21 Semtech (SMTC) Downgraded from Outperform to Market Perform at Northland South Bow (SOBO) Downgraded from Equalweight to Underweight at Barclays; PT USD 33 INITIATIONS BETA Technologies (BETA) Initiated at Overweight at Barclays; PT USD 35 Biogen (BIIB) Initiated at Outperform at CCB International BellRing Brands (BRBR) Initiated at Outperform at BNP Paribas Exane; PT USD 12 Carrier Global (CARR) Initiated at Overweight at JPMorgan C4 Therapeutics (CCCC) Initiated at Overweight at JPMorgan; PT USD 10 Ducommun (DCO) Initiated at Buy at Guggenheim; PT USD 246 Definium Therapeutics (DFTX) Initiated at Overweight at JPMorgan; PT USD 84 Duos Technologies (DUOT) Initiated at Neutral at Chardan; PT USD 9.50 Fortune Brands Innovations (FBIN) Initiated at Buy at Citi; PT USD 48 GSK (GSK) Initiated at Outperform at Wolfe Research; PT USD 70 IBM (IBM) Initiated at Hold at Truist Securities; PT USD 240 Karman Holdings (KRMN) Initiated at Overweight at Barclays; PT USD 79 LB Pharmaceuticals (LBRX) Initiated at Buy at Canaccord; PT USD 65 El Pollo Loco (LOCO) Initiated at Buy at Roth/MKM; PT USD 22 Macerich (MAC) Initiated at Outperform at BNP Paribas Exane; PT USD 28 Mobility Global (MBGL) Initiated at Equalweight at Morgan Stanley; PT USD 19 Mid Penn Bancorp (MPB) Initiated at Overweight at Piper Sandler; PT USD 42 Ovid Therapeutics (OVID) Initiated at Overweight at Cantor Fitzgerald Plains All American Pipeline (PAA) Initiated at Buy at Jefferies; PT USD 27 Penguin Solutions (PENG) Initiated at Buy at BofA Securities; PT USD 100 Planet Labs (PL) Initiated at Equalweight at Barclays; PT USD 17 Quince Therapeutics (QNCX) Initiated at Outperform at Raymond James; PT USD 72 RMR Group (RMR) Initiated at Buy at Maxim Group; PT USD 26 Sanofi (SNY) Initiated at Peer Perform at Wolfe Research Simon Property (SPG) Initiated at Neutral at BNP Paribas Exane; PT USD 222 Southwest Gas (SWX) Initiated at Peer Perform at Wolfe Research; PT USD 92 Trane Technologies (TT) Initiated at Overweight at JPMorgan Vicore Pharma Holding AB (VCRE) Initiated at Buy at Jefferies; PT USD 25